Epsilon Healthcare appointed Peter Giannopoulos as the new CEO

Epsilon Healthcare Limited (ASX: EPN) has announced Mr. Peter Giannopoulos's appointment to be Chief Executive Officer (CEO), who will begin in the position on May 23, 2023. Mr. Giannopoulos brings to Epsilon more than 25 years of experience in the Australian healthcare ecosystems, including successes in leadership, operations, M&A, GMP manufacturing, the delivery of creative revenue streams, and accretive market opportunities.

He has also achieved success in the ASX healthcare environment. Peter also has clinical experience, a pharmacy degree, and a comprehensive knowledge of the Australian and global health systems. Peter works to optimize business processes and build accountable, scalable, sustainable, and competitive organizations.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com